Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Johnson & Johnson's Prostate Cancer Drug JNJ-6143 Shrinks Tumours In Early Trial

    3 hours ago

    In the early-stage trial, 77% of 31 evaluable patients receiving the 50-milligram dose experienced a PSA decline of at least 50%, while 48% recorded reductions of 90% or more.
    Click here to Read More
    Previous Article
    India Extends Assistance To Its Nationals, Especially Umrah Pilgrims, Stranded In Saudi Arabia
    Next Article
    No Meat In Lok Bhavan Kitchen: Keralam Governor's Day 1 Order Sparks Row

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment